Malaria
疟疾
基本信息
- 批准号:8396987
- 负责人:
- 金额:$ 0.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-15 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAdvanced DevelopmentAffectAnimal ModelAreaBasic ScienceBiological MarkersBiologyCellsCellular biologyCessation of lifeCollaborationsCommunitiesCulicidaeDevelopmentDisciplineDiseaseDrug TargetingDrug resistanceEffectivenessEngineeringFunctional disorderFutureGenerationsGenomeGenomicsGoalsHumanImmune responseImmunityImmunologyIndividualInfectionInfection preventionInterventionInvestigationKnowledgeLeadLifeLouisianaMalariaMalaria VaccinesMeasuresMolecularMolecular and Cellular BiologyOutcomeParasitesParasitic DiseasesPathogenesisPharmaceutical PreparationsPlasmodiumPopulation BiologyPredispositionPublic HealthResearchResearch PersonnelScienceScientistStagingStudentsThinkingVaccinesVirus DiseasesWaterWorkbaseburden of illnessdesigndisorder controlfield studyfunctional genomicsinnovationinterdisciplinary approachinterestmeetingsmultidisciplinarynext generationnovelpathogenpreventprogramspublic health relevanceresponsesymposiumtransmission processvaccine developmentvectorvector mosquito
项目摘要
Description (as provided by the applicant): Support is requested for a Keystone Symposia meeting entitled Malaria, organized by Fidel P. Zavala, Andrew P. Waters, Kevin Marsh and Carolina V. Barillas-Mury. The meeting will be held in New Orleans, Louisiana from January 20 - 25, 2013. Malaria affects hundreds of millions of people and causes nearly 1 million deaths per year. The control and eventual eradication of malaria will require a concerted, multidisciplinary effort to decrease parasite infectivity through vaccines and anti-parasitic drugs, and by preventing transmission to the vertebrate host. In this meeting we will promote discussion of: 1) Innate and adaptive immune responses to Plasmodium infection and how the parasite interferes with these responses. We will also discuss the development of new adjuvants and anti-malaria vaccine strategies. 2) Basic aspects of Plasmodium cellular and population biology that affect infection and the development of drug resistance. 3) Plasmodium transmission, including gametocytogenesis and Plasmodium biology in the mosquito vector. This includes cellular and molecular aspects of parasite-mosquito interactions, field studies, functional genomics and the development of potential control strategies. 4) Severe malaria in endemic areas, recent advances in our understanding of the physiopathology of disease in humans and in animal models, and genome-based strategies to identify biomarkers of susceptibility to severe disease. Since basic and translational malaria research is eminently multidisciplinary, the 2013 Keystone Symposia meeting on Malaria will bring together researchers working in disciplines ranging from basic molecular studies to population biology. This encounter will promote the exchange of ideas to both deepen our understanding of malaria and to develop novel control measures. Furthermore, we anticipate that this meeting will enable us to identify and prioritize the next generation of challenges faced by the field.
说明(如申请者所提供):请求为Fidel P. Zavala、Andrew P.沃茨、Kevin Marsh和卡罗莱纳V. Barillas-Mury组织的题为疟疾的Keystone专题讨论会提供支助。会议将于2013年1月20日至25日在路易斯安那州新奥尔良举行。疟疾影响数亿人,每年造成近100万人死亡。控制和最终消灭疟疾将需要协调一致的多学科努力,通过疫苗和抗寄生虫药物以及通过防止传播给脊椎动物宿主来减少寄生虫感染。在这次会议中,我们将促进讨论:1)对疟原虫感染的先天性和适应性免疫反应以及寄生虫如何干扰这些反应。我们还将讨论新佐剂和抗疟疾疫苗策略的开发。2)影响感染和抗药性发展的疟原虫细胞和种群生物学的基本方面。3)疟原虫传播,包括配子体发生和蚊媒中的疟原虫生物学。这包括寄生虫-蚊子相互作用的细胞和分子方面,实地研究,功能基因组学和潜在控制策略的发展。4)流行地区的严重疟疾,我们对人类和动物模型疾病的生理病理学的理解的最新进展,以及基于基因组的策略,以确定对严重疾病易感性的生物标志物。由于基础和转化疟疾研究是非常多学科的,2013年疟疾问题基石研讨会将汇集从基础分子研究到人口生物学等学科的研究人员。这次会议将促进思想交流,以加深我们对疟疾的了解,并制定新的控制措施。此外,我们预计,本次会议将使我们能够确定实地面临的下一代挑战并确定其优先次序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Wavell Aiken其他文献
James Wavell Aiken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Wavell Aiken', 18)}}的其他基金
Type 2 Immunity: Initiation, Maintenance, Homeostasis and Pathology
2 型免疫:启动、维持、稳态和病理
- 批准号:
8399493 - 财政年份:2013
- 资助金额:
$ 0.9万 - 项目类别:
Emerging Topics in Immune System Plasticity: Cellular Networks, Metabolic Control
免疫系统可塑性的新兴主题:细胞网络、代谢控制
- 批准号:
8400276 - 财政年份:2013
- 资助金额:
$ 0.9万 - 项目类别:
Frontiers in HIV Pathogenesis, Therapy and Eradication
HIV发病机制、治疗和根除的前沿
- 批准号:
8260640 - 财政年份:2012
- 资助金额:
$ 0.9万 - 项目类别:
NF-kappaB Signaling and Biology: From Bench to Bedside
NF-kappaB 信号传导和生物学:从实验室到临床
- 批准号:
8253117 - 财政年份:2012
- 资助金额:
$ 0.9万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别: